These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6823693)
1. Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Donohoe JA; Andrus L; Bowen KM; Simeonovic C; Prowse SJ; Lafferty KJ Transplantation; 1983 Jan; 35(1):62-7. PubMed ID: 6823693 [TBL] [Abstract][Full Text] [Related]
2. Effect of organ culture on the survival of thyroid allografts in mice. Lafferty KJ; Bootes A; Dart G; Talmage DW Transplantation; 1976 Aug; 22(2):138-49. PubMed ID: 61634 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of thyroid allograft rejection. Lafferty KJ; Bootes A; Killby VA; Burch W Aust J Exp Biol Med Sci; 1976 Dec; 54(6):573-86. PubMed ID: 1027412 [TBL] [Abstract][Full Text] [Related]
4. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Wong W; Morris PJ; Wood KJ Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815 [TBL] [Abstract][Full Text] [Related]
6. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state. Coulombe M; Gill RG Transplantation; 1994 Apr; 57(8):1195-200. PubMed ID: 8178346 [TBL] [Abstract][Full Text] [Related]
7. Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third-party grafts bearing new antigens when associated with tolerogenic antigens. La Rosa FG; Smilek D; Talmage DW; Lafferty KJ; Bauling P; Ammons TJ Transplantation; 1992 Apr; 53(4):903-13. PubMed ID: 1566357 [TBL] [Abstract][Full Text] [Related]
8. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen. Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294 [TBL] [Abstract][Full Text] [Related]
9. Effect of in vivo exposure to allogeneic cells upon subsequent in vitro T cell responses and upon allograft rejection. Cooley MA Scand J Immunol; 1978; 7(5):371-80. PubMed ID: 149361 [TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue immunogenicity by organ culture. Comparison of adult islets and fetal pancreas. Simeonovic CJ; Bowen KM; Kotlarski I; Lafferty KJ Transplantation; 1980 Sep; 30(3):174-9. PubMed ID: 14582172 [TBL] [Abstract][Full Text] [Related]
11. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells. Warren HS; Pembrey RG Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539 [TBL] [Abstract][Full Text] [Related]
12. Stabilization of islet allografts by treatment of recipients with ultraviolet irradiated donor spleen cells. Agostino M; Prowse SJ; Lafferty KJ Aust J Exp Biol Med Sci; 1983 Oct; 61 ( Pt 5)():517-27. PubMed ID: 6419715 [TBL] [Abstract][Full Text] [Related]
13. Thyroid allograft immunogenicity is reduced after a period in organ culture. Lafferty KJ; Cooley MA; Woolnough J; Walker KZ Science; 1975 Apr; 188(4185):259-61. PubMed ID: 1118726 [TBL] [Abstract][Full Text] [Related]
14. Initiation of rejection of established islet allografts by third-party thyroid allografts and splenic dendritic cells. Kover K; Moore WV Diabetes; 1991 Jun; 40(6):754-8. PubMed ID: 2040391 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of thyroid allograft survival following organ culture: II. Induction of recipient peripheral tolerance. Hullett DA; Sollinger HW Hum Immunol; 1997 Feb; 52(2):127-37. PubMed ID: 9077561 [TBL] [Abstract][Full Text] [Related]
16. Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: vascular and cytokine analysis after transient CD4 T cell depletion. Mottram PL; Raisanen-Sokolowski A; Glysing-Jensen T; Stein-Oakley AN; Russell ME Transplantation; 1998 Dec; 66(11):1510-8. PubMed ID: 9869093 [TBL] [Abstract][Full Text] [Related]
17. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489 [TBL] [Abstract][Full Text] [Related]
18. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053 [TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
20. Is a specialized stimulator cell required for the induction of allograft immunity? Lafferty KJ; Bootes A; Dart G; Radovich G; Talmage DW Adv Exp Med Biol; 1976; 66():87-93. PubMed ID: 1266680 [No Abstract] [Full Text] [Related] [Next] [New Search]